| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1374917 | Bioorganic & Medicinal Chemistry Letters | 2009 | 4 Pages |
Abstract
The evaluation of a series of piperazinyl carbamates and ureas, designed on the basis of previously reported TRPV1 antagonists and FAAH inhibitors, led to the identification of some ‘dual-action’ compounds targeting both FAAH and TRPV1 or TRPA1 receptors.
Graphical abstractThe evaluation of a series of piperazinyl carbamates and ureas, designed on the basis of previously reported TRPV1 antagonists and FAAH inhibitors, led to the identification of some ‘dual-action’ compounds targeting both FAAH and TRPV1 or TRPA1 channels.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Enrico Morera, Luciano De Petrocellis, Ludovica Morera, Aniello Schiano Moriello, Alessia Ligresti, Marianna Nalli, David F. Woodward, Vincenzo Di Marzo, Giorgio Ortar,
